Simparica Trio 2.6-5kg

Dogs should be tested for existing heartworm infestation prior to administration of Simparica Trio. At the discretion of the veterinarian, infested dogs should be treated with an adulticide to remove adult heartworms. Simparica Trio is not indicated for microfilariae clearance.

Use with caution in dogs with a history of seizures. Simparica Trio contains sarolaner, a member of the isoxazoline class, which has been associated with neurologic adverse reactions including tremors, ataxia, and seizures in dogs with or without history of neurologic disorders. The safe use of Simparica Trio has not been evaluated in breeding, pregnant, or lactating dogs. The most common frequently reported adverse reactions in clinical trials were vomiting and diarrhoea. For more information, contact your veterinarian.